drugset / Trial / NCT00276263
Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether preventative treatment with sarcosine can reduce symptoms and delay/avoid disease progression in individuals defined as being in a prodromal stage of schizophrenia.
Timeline
- Start
- 2006-08
- Primary completion
- —
- Completion
- 2009-06
Outcome
Outcome not reported
Stopped: “lack of participants”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sarcosine | Other / unclassified | 2 g | — |